Pricing Log in Create free account

CytoMed Therapeutics Limited (GDTC) vs Tempest Therapeutics, Inc. (TPST)

CytoMed Therapeutics Limited and Tempest Therapeutics, Inc. are both Biotechnology companies. CytoMed Therapeutics Limited and Tempest Therapeutics, Inc. are of similar size ($10.7M and $10.3M). Across the 8 metrics below, CytoMed Therapeutics Limited leads on 5 and Tempest Therapeutics, Inc. on 3.

Valuation

Metric GDTC TPST Biotechnology median
P/E n/m n/m 8.50
P/S n/m 29.13 9.71
P/B 0.57 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 33.65 9.21
Earnings yield (31.82%) (690.32%) (33.15%)
Free cash flow yield (0.38%) (224.23%) (25.50%)

Profitability

Metric GDTC TPST Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (931.14%) (56.36%)
Return on assets 0.00% (237.25%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GDTC TPST Biotechnology median
Revenue growth (TTM) — (52.98%) 6.02%
EPS growth (last fiscal year) (68.75%) 67.55% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GDTC TPST Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 2.64 0.38 4.72
Net debt to EBITDA 0.86 0.29 0.96

Dividend

Metric GDTC TPST Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GDTC TPST Biotechnology median
Market cap 10.30m 10.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack